Publications in collaboration with researchers from University of the Witwatersrand (2)

2020

  1. BAY 81-8973 demonstrated efficacy, safety and joint status improvement in patients with severe haemophilia A in the LEOPOLD I extension for ≤2 years

    European Journal of Haematology, Vol. 104, Núm. 6, pp. 594-601

2016

  1. Efficacy and safety of long-acting recombinant fusion protein linking factor IX with albumin in haemophilia B patients undergoing surgery

    Haemophilia, Vol. 22, Núm. 4, pp. e259-e266